TECELRA® launch momentum accelerating – 10 patients apheresed in Q1 2025 and 3 in 2024; 20 ATCs available; all manufacturing and supply goals ...

Years ago, a family member was diagnosed with an extremely rare cancer: Liposarcoma of the Spermatic Cord. Fewer than 200 ...

Myxoid liposarcoma of the head and neck is an extremely rare entity. The scalp region represents a risk factor to the patient because the diagnosis is usually made late, and the surgeon must have ...

Reference D’Angelo SP, Araujo DM, Abdul Razak AR, et al. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label ...

Because liposarcoma is rare, commonly recurs, and has evolving treatments, it cannot be overemphasized that patients should be referred to specialized cancer treatment centers where a larger ...

Pembrolizumab is under clinical development by Merck and currently in Phase II for Myxoid Liposarcoma. According to GlobalData, Phase II drugs for Myxoid Liposarcoma does not have sufficient ...

As doctors learn more about the biology of sarcoma cells, targeted therapy is becoming an important treatment option for some soft tissue sarcomas. Pazopanib blocks several cell enzymes called ...